-
Nanocrystalline Drug Delivery Systems for Natural Compounds: Progress, Challenges and Future Opportunities
17 Sep 2025 17:46 GMT
… remedies in the realm of drug development.6
Despite their considerable medicinal … for the treatment of bronchopulmonary aspergillosis. … effects of sorafenib against advanced hepatocellular … polysaccharide nanocrystals as pharmaceutical excipients. Carbohydr Polym. …
-
CYP2C8-Mediated Drug–Drug Interactions and the Factors Influencing the Interaction Magnitude
16 Sep 2025 09:22 GMT
… who was receiving eight medications (metformin, pioglitazone, sitagliptin … drug monitoring of sorafenib N-oxide during sorafenib treatment … comedicate with statins.85
Antidepressants
Fluvoxamine is … transporter proteins, and pharmaceutical practice for the …
-
Boosting Sorafenib Efficacy via Dipeptidyl Peptidase 9 Inhibition
09 Sep 2025 05:50 GMT
… nature and resistance to standard treatments. Sorafenib, a first-line oral multikinase … of research initiatives and clinical trials aimed at evaluating DPP9 inhibitors … innovative ways of using existing drugs — like sorafenib — will rise to the …
-
How to keep cancer drugs affordable after LDC graduation
03 Sep 2025 10:17 GMT
… that have kept essential medicines affordable, particularly for … generic cancer drugs. For instance, Beacon Pharmaceuticals produces Tagrix, … to produce sorafenib, a liver cancer drug, slashing the … subsidy programmes for cancer treatment are needed to shield …
-
Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity
02 Sep 2025 16:45 GMT
… progress of modern medicine and biotechnology, the research … . Furthermore, randomized trials and meta-analyses … treatments like arsenic trioxide, molecularly targeted drugs (eg, TKIs such as sorafenib … YAP1 expression. Acta Pharmaceutica Sinica B. 2021 …
-
Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma
27 Aug 2025 11:56 GMT
… Medical Products Administration (NMPA) to serve as a first-line treatment … can they assist drug clinical trials? Expert Opin Invest Drugs. 2022;31( … multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with …
-
Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China
23 Aug 2025 17:16 GMT
… plus sorafenib.6,7 Similarly, large randomized trials … retrospectively extracted from electronic medical records, including demographic … -analysis. Front Bioeng Biotechnol. 2022;10:1010824. … Donafenib versus sorafenib in first-line treatment of unresectable …
-
VEGFR-2 Inhibitors Market Set To Transform Oncology Treatment Landscape By 2034 Delveinsight
21 Aug 2025 23:12 GMT
… rivoceranib to sorafenib as … treatments.
The drug is being studied in several trials: Phase III trials … for medical innovation and … Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical …
-
A Comparative Study of Five Large Language Models’ Response for Liver Cancer Comprehensive Treatment
19 Aug 2025 18:39 GMT
… screening, treatment methods, postoperative care and medication guidance, … therapeutic specifications (eg, sorafenib 400 mg bid); … overall, occasionally hallucinated drug combinations (eg, pairing … Language Inference over Clinical Trials. In: Hauff C …
-
Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy
18 Aug 2025 13:57 GMT
… Chinese Medicine” OR “Chinese herbal medicine” OR “Chinese medicinal herb” … have significantly improved treatment efficacy, drug resistance often emerges, … enhances apoptosis in sorafenib-resistant HCC cells, … cells. J Microbiol Biotechnol. 2025;35:e2501025. …